Childhood cancer and the Jehovah's Witness faith. (odpre novo okno)

Frankel LS, Damme CJ, Eys JV.

Vir‎: Pediatrics 1977;60(6):916-21.

Indeksirano‎: PubMed 600607

https://www.ncbi.nlm.nih.gov/pubmed/600607 (odpre novo okno)

Gemtuzumab ozogamicin in children and adolescents with de novo acute myeloid leukemia improves event-free survival by reducing relapse risk: results from the randomized phase III Children's Oncology Group trial AAML0531. (odpre novo okno)

Gamis AS, Alonzo TA, Meshinchi S, Sung L, Gerbing RB, Raimondi SC, Hirsch BA, Kahwash SB, Heerema-McKenney A, Winter L, Glick K, Davies SM, Byron P, Smith FO, Aplenc R

Vir‎: J Clin Oncol 2014;32(27):3021-32.

Indeksirano‎: PubMed 25092781

DOI‎: 10.1200/JCO.2014.55.3628

https://www.ncbi.nlm.nih.gov/pubmed/25092781 (odpre novo okno)

Red blood cell transfusion and outcome in cancer. (odpre novo okno)

Iqbal N, Haider K, Sundaram V, Radosevic J, Burnouf T, Seghatchian J, Goubran H

Vir‎: Transfus Apher Sci 2017;56(3):287-90.

Indeksirano‎: PubMed 28602484

DOI‎: 10.1016/j.transci.2017.05.014

https://www.ncbi.nlm.nih.gov/pubmed/28602484 (odpre novo okno)

Bloodless cancer treatment results of patients who do not want blood transfusion: single center experience of 77 cases. (odpre novo okno)

Oh SY, Kim SH, Kwon HC, Lee S, Kim KH, Kwon KA, Lee JH, Lee KY, Kim HJ

Vir‎: Support Care Cancer 2010;18(10):1341-6.

Indeksirano‎: PubMed 19841950

DOI‎: 10.1007/s00520-009-0759-3

https://www.ncbi.nlm.nih.gov/pubmed/19841950 (odpre novo okno)